{"id":213,"date":"2024-10-30T18:48:27","date_gmt":"2024-10-30T18:48:27","guid":{"rendered":"https:\/\/iims.uthscsa.edu\/isrn\/?page_id=213"},"modified":"2024-11-07T15:45:56","modified_gmt":"2024-11-07T15:45:56","slug":"a-translational-interdisciplinary-approach-to-decrease-and-prevent-mucositis-in-the-oncology-unit-using-the-iowa-model-to-promote-quality-care-abstract","status":"publish","type":"page","link":"https:\/\/iims.uthscsa.edu\/isrn\/resources\/ereading-room\/abstracts\/a-translational-interdisciplinary-approach-to-decrease-and-prevent-mucositis-in-the-oncology-unit-using-the-iowa-model-to-promote-quality-care-abstract\/","title":{"rendered":"A Translational Interdisciplinary Approach to Decrease and Prevent Mucositis in the Oncology Unit using the Iowa Model to Promote Quality Care"},"content":{"rendered":"

[vc_row][vc_column width=”2\/3″][vc_column_text css=””]<\/p>\n

\n\n\n\n\n\n
Principal Investigator:<\/td>\nShirley E. Harvey, RN, BSN, OCN<\/td>\n<\/tr>\n
Co-Principal Investigators\/Collaborators:<\/td>\nMay Dean, Kathy Baker, Ashley Netting, Megan Ogle, Anne Fredrich-Cuntz, John Adams, Bill Brown, Dora Mendoza, Melissa Cole<\/td>\n<\/tr>\n
Organization:<\/td>\nTexas Health Resource Arlington Memorial Hospital<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Abstract<\/h2>\n

Problem and Change Needed<\/h3>\n

Mucositis is a common toxicity associated with chemotherapy and radiation therapy. It is a complex process that begins with the initiation of chemotherapy or radiation and my last for weeks until healing is completed. At Texas Health Arlington Memorial Hospital, there was no structured protocol for preventing or treating mucosistits. This led to confusion and inconsistency for the staff and patients.<\/p>\n

Evidence<\/h3>\n

The goal of this project was to develop a policy and protocol by an interdisciplinary team based on the Oncology Nursing Society’s (ONS) “Putting Evidence into Practice” (PEP) guidelines for mucositis. Team members were representative of nursing, research, education, nutrition, pharmacy, and medicine. We did a literature review to support and validate ONS’s information.<\/p>\n

Strategy<\/h3>\n

Using the Iowa Model to Promote Quality Care, we developed a policy, protocol, and algorithm to prevent and treat mucositis. We educated both the patients and staff.<\/p>\n

Practice Change<\/h3>\n

We now use bland salt and soda rinses and have eliminated products such as magic mouth wash from our hospital formulary. We have eliminated products which contain per ox-A-mint from our floor stock.<\/p>\n

Evaluation<\/h3>\n

We monitored patient comfort and knowledge before and after implementation and found a decrease in discomfort post interventions.<\/p>\n

Results<\/h3>\n

Due to the success of the policy on our oncology unit, our policy has been revised and combined with the existing oral care and dysphagia policies for the general hospital population.<\/p>\n

Recommendations<\/h3>\n

The process that we followed using the Iowa model was successful. We hope to follow this model again as we develop policies for implementing additional ONS PEP guidelines.<\/p>\n

Lessons Learned<\/h3>\n

Some of the nursing and medical staff were slow to change their practice and were content to use the old products which were ineffective. In the future I would continue to use an interdisciplinary team but include more staff members to ensure continued collaboration.<\/p>\n

Bibliography<\/h3>\n